XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jul. 01, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 217.1 $ 167.2
Trade accounts receivable, less allowances of $32.3 and $34.4 at July 1, 2023 and December 31, 2022, respectively 1,415.2 1,374.4
Inventories 990.5 1,009.9
Other current assets 228.2 230.5
Total current assets 2,851.0 2,782.0
Property, plant and equipment, net 1,567.0 1,540.2
Goodwill 1,985.1 1,862.4
Other intangibles resulting from business acquisitions, net 883.8 840.3
Deferred tax assets 119.7 115.1
Other assets 859.7 810.5
Total Assets 8,266.3 7,950.5
Current liabilities:    
Short-term borrowings and current portion of long-term debt and finance leases 635.8 598.6
Accounts payable 1,234.8 1,339.3
Accrued payroll and employee benefits 178.9 228.5
Other current liabilities 559.2 633.4
Total current liabilities 2,608.7 2,799.8
Long-term debt and finance leases 2,909.7 2,503.5
Long-term retirement benefits and other liabilities 475.0 367.1
Deferred tax liabilities and income taxes payable 257.7 247.9
Commitments and contingencies (see Note 11)
Shareholders’ equity:    
Common stock, $1 par value per share, authorized – 400,000,000 shares at July 1, 2023 and December 31, 2022; issued – 124,126,624 shares at July 1, 2023 and December 31, 2022; outstanding – 80,650,885 shares and 80,810,016 shares at July 1, 2023 and December 31, 2022, respectively 124.1 124.1
Capital in excess of par value 851.3 879.3
Retained earnings 4,526.9 4,414.6
Treasury stock at cost, 43,475,739 shares and 43,316,608 shares at July 1, 2023 and December 31, 2022, respectively (3,093.9) (3,021.8)
Accumulated other comprehensive loss (393.2) (364.0)
Total shareholders’ equity 2,015.2 2,032.2
Liabilities and Shareholders’ Equity $ 8,266.3 $ 7,950.5